Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Glutamate
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Stavzor
(valproic acid oral) / Thermo Fisher Scientific, Hisamitsu
AAV-GAD gene therapy
/ MeiraGTx
AZD2516
/ AstraZeneca
NYX-2925
/ Aptinyx
botulinum toxin A topical
(ET-01) / Eirion
raseglurant
(ADX-10059) / Addex
acamprosate controlled-release
(SNC-102) / Synchroneuron
botulinum toxin A longer acting
(IPN10200) / Ipsen
Exservan
(riluzole oral soluble film) / Aquestive, Zambon, Mitsubishi Tanabe
KLS-2031
/ Kolon Life Sci
LY545694
/ Eli Lilly
acamprosate/baclofen
(PXT-864) / Pharnext
anhydrous enol-oxaloacetate
(AEO) / MetVital
clostridium botulinum neurotoxin serotype A recombinant
(IPN59011) / Ipsen
AMT-260
/ uniQure
CVXL-0107
/ CleveXel Pharma
NYX-458
/ Aptinyx
botulinum toxin A injection
(AI-09) / Eirion
tianeptine hemioxalate extended-release
(TNX-601 ER) / Tonix